Picture of Neuroone Medical Technologies logo

NMTC Neuroone Medical Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m+3.32%
3m-20.85%
6m+2.93%
1yr-41.1%
Volume Change (%)
10d/3m-42.99%
Price vs... (%)
52w High-42.72%
50d MA-3.82%
200d MA-1.39%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-305.5%
Return on Equity-214.01%
Operating Margin-474.79%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Sep 202430th Sep 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Neuroone Medical Technologies EPS forecast chart

Profile Summary

NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.

Directors

    Last Annual
    September 30th, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    June 26th, 2017
    Public Since
    November 9th, 2012
    No. of Shareholders
    103
    No. of Employees
    16
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    us flag iconNASDAQ Capital Market
    Shares in Issue
    25,930,926

    NMTC Share Price Performance

    Upcoming Events for NMTC

    Q2 2024 Neuroone Medical Technologies Corp Earnings Release

    Q3 2024 Neuroone Medical Technologies Corp Earnings Release

    Similar to NMTC

    Picture of Accelerate Diagnostics logo

    Accelerate Diagnostics

    us flag iconNASDAQ Capital Market

    Picture of Acutus Medical logo

    Acutus Medical

    us flag iconNASDAQ Capital Market

    Picture of Adapthealth logo

    Adapthealth

    us flag iconNASDAQ Capital Market

    Picture of Aethlon Medical logo

    Aethlon Medical

    us flag iconNASDAQ Capital Market

    Picture of Agape ATP logo

    Agape ATP

    us flag iconNASDAQ Capital Market

    FAQ